Intraocular Pressure

Cigna Healthcare has updated its glaucoma surgical procedure policy to cover both ab interno canaloplasty and goniotomy to treat primary open-angle glaucoma, according to a press release from Sight Sciences.

Canaloplasty and trabeculotomy performed with the Omni surgical system provided patients with glaucoma with sustained IOP control over 2 years, according to a study published in Clinical Ophthalmology.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Arkadiy Yadgarov, MD, discusses real-world data of canaloplasty and trabeculotomy using the Omni surgical system from Sight Sciences.

The FDA accepted a new drug application for iDose TR, an intraocular implant designed to continuously deliver travoprost to lower IOP in open-angle glaucoma or ocular hypertension, according to a Glaukos press release.

NEW ORLEANS — Greater use of certain types of alcohol is associated with elevated IOP but not glaucoma, according to a poster presentation at the Association for Research in Vision and Ophthalmology meeting.

VILAMOURA, Portugal — Minimally invasive glaucoma surgery with the PreserFlo microshunt leads to good IOP control with minimal anterior segment parameter variations, according to a study presented here.

Celanese has entered into an agreement with Glaukos to supply the VitalDose drug delivery platform for Glaukos’ iDose TR, according to a press release.

In this Healio Video Perspective from the EnVision Summit, Constance O. Okeke, MD, MSCE, discusses the mechanism of action and efficacy of Vyzulta to treat glaucoma.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Thurein Htoo, MS, MBA, CEO and co-founder of Qlaris Bio, discusses study results for QLS-111.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Savas Komban, CEO and co-founder of Smartlens, discusses developments in unmet needs in glaucoma, including IOP assessment.